Literature DB >> 17304640

Phenylboronate 160Tb complexes for molecular recognition of glycoproteins expressed on tumor cells.

Kristina Djanashvili1, Gerben A Koning, Astrid J G M van der Meer, Hubert Th Wolterbeek, Joop A Peters.   

Abstract

The over-expression of sialic acid on the surface of cancer cells compared with normal ones makes this nine-carbon sugar an attractive biomarker for molecular diagnosis and therapy. Here, we describe a study on the molecular recognition of sialic acid end groups on the surface of human glioma cells by (160)Tb-DTPA-EN(2), (160)Tb-DTPA-(ENPBA)(2) and (160)Tb-DTPA-(PBA)(2) complexes. The results show Tb-DTPA-(ENPBA)(2) to be the most efficient targeting agent, due to the electrostatic interaction between its two positively charged ammonium groups and the negatively charged cell surface, which provides an additional stabilization of the covalent binding through the PBA moieties and the sialic acid diol functions. Up to 5.5 nmol Tb/mg protein is taken up by the cells. ICP analysis after incubation experiments with non-radioactive Tb-DTPA-(ENPBA)(2) suggests that dissociation of Tb from this complex occurs after its binding to the cell surface. Most likely, most of the free Tb remains adsorbed on the surface of the cells, although internalization of a small amount cannot be excluded. Copyright 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17304640     DOI: 10.1002/cmmi.123

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  4 in total

1.  Tumor Targeting via Sialic Acid: [68Ga]DOTA-en-pba as a New Tool for Molecular Imaging of Cancer with PET.

Authors:  Charalambos Tsoukalas; Simonetta Geninatti-Crich; Anastasios Gaitanis; Theodoros Tsotakos; Maria Paravatou-Petsotas; Silvio Aime; Rogelio Jiménez-Juárez; Constantinos D Anagnostopoulos; Kristina Djanashvili; Penelope Bouziotis
Journal:  Mol Imaging Biol       Date:  2018-10       Impact factor: 3.488

Review 2.  'Borono-lectin' based engineering as a versatile platform for biomedical applications.

Authors:  Akira Matsumoto; Yuji Miyahara
Journal:  Sci Technol Adv Mater       Date:  2017-12-19       Impact factor: 8.090

3.  Heterocyclic boronic acids display sialic acid selective binding in a hypoxic tumor relevant acidic environment.

Authors:  A Matsumoto; A J Stephenson-Brown; T Khan; T Miyazawa; H Cabral; K Kataoka; Y Miyahara
Journal:  Chem Sci       Date:  2017-07-05       Impact factor: 9.825

4.  Towards Enhanced MRI Performance of Tumor-Specific Dimeric Phenylboronic Contrast Agents.

Authors:  Jonathan Martinelli; Lorenzo Tei; Simonetta Geninatti Crich; Diego Alberti; Kristina Djanashvili
Journal:  Molecules       Date:  2021-03-19       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.